•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Old Frontpage Layout

Save preferences

Veritas, Khaitan on $100m Recipharm infusion in Nitin Lifesciences

Veritas Legal advised Recipharm AB, a Swedish pharmaceutical company on investing $103m (Rs 671.2 crore) in Nitin Lifesciences, an Indian pharma company which was advised by Khaitan & Co.

Veritas partner Partner Nandish Vyas and Associates Natasha Sethna and Tejasvi Saxena acted for Recipharm.

Khaitan Mumbai partner Kalpana Unadkat, senior associate Shweta Dwivedi and associate Bidya Mohanty acted for Nitin Lifesciences.

Recipharm, will buy 74 per cent in Nitin Lifesciences, reported Livemint

No comments yet: share your views

Latest comments